A phase I double-blind trial investigating trachoma vaccine regimens using the Chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02)

Pollock K.

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier

Publication Date

27/02/2024

Permalink